logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
APLM
Apollomics, Inc.
19.02
1 x 17.86
2 x 18.28
bid
ask
+
0.31
1.66%
04:00 PM
timesize
Ytd1.71%
1y192.62%
18.20
day range
19.02
3.66
52 week range
42.12
Open18.20Prev Close18.71Low18.20High19.02Mkt Cap20.64M
Vol2.76KAvg Vol17.30KEPS-13.12P/E-1.43Forward P/E-17.31
Beta1.44Short Ratio0.07Inst. Own2.09%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg16.53200-d Avg17.741yr Est0.00

APLM News

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday&#3

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Agenus (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session
benzinga.com
Apollomics Regains Nasdaq Compliance

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical

Apollomics Regains Full Compliance with Nasdaq Listing Requirements
globenewswire.com
Apollomics Regains Full Compliance with Nasdaq Listing Requirements

FOSTER CITY, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics”
benzinga.com
Apollomics Receives Nasdaq Noncompliance Notice, Gets Time Through Dec. 15 To Regain Compliance; Ter

Apollomics Inc. (Nasdaq: APLM) ("Apollomics" or the "Company"), a late-stage clinica

Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
globenewswire.com
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates

FOSTER CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics”
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
Apollomics FY EPS $(7.57) Up From $(52.80) YoY, Sales $8.500M

Apollomics (NASDAQ:APLM) reported quarterly losses of $(7.57) per share. This is a 85.66 percent inc

Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
globenewswire.com
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progr

Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and

Apollomics Inc. Announces $2.0 Million Bridge Financing
globenewswire.com
Apollomics Inc. Announces $2.0 Million Bridge Financing

FOSTER CITY, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics Inc. (NASDAQ:APLM) Short Interest Down 30.9% in March
defenseworld.net
Apollomics Inc. (NASDAQ:APLM) Short Interest Down 30.9% in March

Apollomics Inc. (NASDAQ: APLM - Get Free Report) was the target of a large decline in short interest

Apollomics Inc. (NASDAQ:APLM) Sees Large Decline in Short Interest
defenseworld.net
Apollomics Inc. (NASDAQ:APLM) Sees Large Decline in Short Interest

Apollomics Inc. (NASDAQ: APLM - Get Free Report) was the recipient of a large decline in short inter

Apollomics Reports First Half 2025 Financial Results
globenewswire.com
Apollomics Reports First Half 2025 Financial Results

FOSTER CITY, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics”

Apollomics Announces Settlement of Cayman Litigation
globenewswire.com
Apollomics Announces Settlement of Cayman Litigation

FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company

Apollomics Announces Changes to its Board of Directors and Composition of Committees
globenewswire.com
Apollomics Announces Changes to its Board of Directors and Composition of Committees

FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
globenewswire.com
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation

FOSTER CITY, Calif. , Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) ("Apollomics"

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
globenewswire.com
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation

FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Nasdaq Resumes Trading in Apollomics Inc.
globenewswire.com
Nasdaq Resumes Trading in Apollomics Inc.

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that t

Apollomics, Inc. Company Operational Continuity Update
globenewswire.com
Apollomics, Inc. Company Operational Continuity Update

FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
globenewswire.com
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Pro

FOSTER CITY, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
globenewswire.com
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib

FOSTER CITY, Calif. and TAIPEI, Taiwan, March 31, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq:

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
globenewswire.com
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients

FOSTER CITY, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
globenewswire.com
Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement

FOSTER CITY, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (the “Company”

Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
globenewswire.com
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FOSTER CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
globenewswire.com
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

FOSTER CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”

Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
globenewswire.com
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion So

43% overall response rate: Six confirmed responses (including one complete response in metastatic no
benzinga.com
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Mon

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the co